Moleculin Biotech, Inc. (MBRX)
4.34
+0.12
(+2.94%)
USD |
NASDAQ |
Feb 13, 16:00
4.37
+0.03
(+0.69%)
After-Hours: 20:00
Moleculin Biotech Total Assets (Quarterly) : 20.35M for Sept. 30, 2025
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| ACADIA Pharmaceuticals, Inc. | 1.331B |
| Alnylam Pharmaceuticals, Inc. | 5.026B |
| Savara, Inc. | 140.92M |
| BioMarin Pharmaceutical, Inc. | 7.615B |
| Imunon, Inc. | 8.988M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 47.27M |
| Shareholders Equity (Quarterly) | -26.92M |
| Debt to Equity Ratio | -0.0145 |
| Current Ratio | 1.388 |
| Net Debt Paydown Yield | 0.11% |